Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:25:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.2, and older notices about government funding and operating status have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:44:52.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A new site-wide notice warns that information may not be up to date due to a lapse in government funding, with guidance to check cc.nih.gov and opm.gov for updates. The page revision also updates to Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T00:39:12.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Minor UI/text updates include a new 'Show glossary' option, capitalization/phrase tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the site revision 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:45:53.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The update is a site revision: Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T17:46:36.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page now uses a consolidated Locations section listing Florida, Michigan, Oregon, and Texas, replacing the previous per-location pages. The HHS Vulnerability Disclosure link was removed from the footer, and the page version updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T08:20:14.000Z thumbnail image

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.